nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfamethoxazole—UGT1A9—Irinotecan—pancreatic cancer	0.205	0.273	CbGbCtD
Sulfamethoxazole—ALB—Erlotinib—pancreatic cancer	0.0705	0.0937	CbGbCtD
Sulfamethoxazole—CYP2C8—Tamoxifen—pancreatic cancer	0.0641	0.0852	CbGbCtD
Sulfamethoxazole—ALB—Irinotecan—pancreatic cancer	0.0636	0.0846	CbGbCtD
Sulfamethoxazole—ALB—Fluorouracil—pancreatic cancer	0.0611	0.0812	CbGbCtD
Sulfamethoxazole—CYP2C8—Erlotinib—pancreatic cancer	0.0545	0.0724	CbGbCtD
Sulfamethoxazole—CYP2C8—Fluorouracil—pancreatic cancer	0.0472	0.0628	CbGbCtD
Sulfamethoxazole—CYP2C9—Tamoxifen—pancreatic cancer	0.0447	0.0594	CbGbCtD
Sulfamethoxazole—CYP2C9—Fluorouracil—pancreatic cancer	0.0329	0.0438	CbGbCtD
Sulfamethoxazole—CYP3A4—Tamoxifen—pancreatic cancer	0.026	0.0345	CbGbCtD
Sulfamethoxazole—CYP3A4—Erlotinib—pancreatic cancer	0.0221	0.0294	CbGbCtD
Sulfamethoxazole—CYP3A4—Irinotecan—pancreatic cancer	0.0199	0.0265	CbGbCtD
Sulfamethoxazole—CYP3A4—Docetaxel—pancreatic cancer	0.0146	0.0194	CbGbCtD
Sulfamethoxazole—CYP3A4—Sunitinib—pancreatic cancer	0.0146	0.0194	CbGbCtD
Sulfamethoxazole—CYP3A4—Doxorubicin—pancreatic cancer	0.0109	0.0145	CbGbCtD
Sulfamethoxazole—Urethral disorder—Docetaxel—pancreatic cancer	0.000397	0.0016	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000397	0.0016	CcSEcCtD
Sulfamethoxazole—Anorexia—Irinotecan—pancreatic cancer	0.000397	0.0016	CcSEcCtD
Sulfamethoxazole—Hyponatraemia—Epirubicin—pancreatic cancer	0.000396	0.0016	CcSEcCtD
Sulfamethoxazole—Skin disorder—Gemcitabine—pancreatic cancer	0.000394	0.00159	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000391	0.00157	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.00039	0.00157	CcSEcCtD
Sulfamethoxazole—Dizziness—Tamoxifen—pancreatic cancer	0.00039	0.00157	CcSEcCtD
Sulfamethoxazole—Dermatitis exfoliative—Doxorubicin—pancreatic cancer	0.000387	0.00156	CcSEcCtD
Sulfamethoxazole—Anorexia—Gemcitabine—pancreatic cancer	0.000386	0.00156	CcSEcCtD
Sulfamethoxazole—Dizziness—Erlotinib—pancreatic cancer	0.000386	0.00155	CcSEcCtD
Sulfamethoxazole—Renal impairment—Doxorubicin—pancreatic cancer	0.000384	0.00155	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Docetaxel—pancreatic cancer	0.000383	0.00154	CcSEcCtD
Sulfamethoxazole—Anorexia—Fluorouracil—pancreatic cancer	0.00038	0.00153	CcSEcCtD
Sulfamethoxazole—Purpura—Doxorubicin—pancreatic cancer	0.000379	0.00153	CcSEcCtD
Sulfamethoxazole—Eye disorder—Docetaxel—pancreatic cancer	0.000378	0.00152	CcSEcCtD
Sulfamethoxazole—Insomnia—Irinotecan—pancreatic cancer	0.000376	0.00152	CcSEcCtD
Sulfamethoxazole—Vomiting—Tamoxifen—pancreatic cancer	0.000375	0.00151	CcSEcCtD
Sulfamethoxazole—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.000374	0.00151	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Sunitinib—pancreatic cancer	0.000372	0.0015	CcSEcCtD
Sulfamethoxazole—Rash—Tamoxifen—pancreatic cancer	0.000372	0.0015	CcSEcCtD
Sulfamethoxazole—Dermatitis—Tamoxifen—pancreatic cancer	0.000371	0.0015	CcSEcCtD
Sulfamethoxazole—Ataxia—Epirubicin—pancreatic cancer	0.000371	0.0015	CcSEcCtD
Sulfamethoxazole—Vomiting—Erlotinib—pancreatic cancer	0.000371	0.00149	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Irinotecan—pancreatic cancer	0.000371	0.00149	CcSEcCtD
Sulfamethoxazole—Headache—Tamoxifen—pancreatic cancer	0.000369	0.00149	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000369	0.00149	CcSEcCtD
Sulfamethoxazole—Rash—Erlotinib—pancreatic cancer	0.000368	0.00148	CcSEcCtD
Sulfamethoxazole—Dermatitis—Erlotinib—pancreatic cancer	0.000368	0.00148	CcSEcCtD
Sulfamethoxazole—Hyponatraemia—Doxorubicin—pancreatic cancer	0.000367	0.00148	CcSEcCtD
Sulfamethoxazole—Insomnia—Gemcitabine—pancreatic cancer	0.000367	0.00148	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Irinotecan—pancreatic cancer	0.000366	0.00148	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Docetaxel—pancreatic cancer	0.000366	0.00147	CcSEcCtD
Sulfamethoxazole—Headache—Erlotinib—pancreatic cancer	0.000365	0.00147	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000365	0.00147	CcSEcCtD
Sulfamethoxazole—Chills—Docetaxel—pancreatic cancer	0.000363	0.00146	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000363	0.00146	CcSEcCtD
Sulfamethoxazole—Asthenia—Sunitinib—pancreatic cancer	0.000362	0.00146	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Irinotecan—pancreatic cancer	0.000362	0.00146	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Gemcitabine—pancreatic cancer	0.000361	0.00146	CcSEcCtD
Sulfamethoxazole—Insomnia—Fluorouracil—pancreatic cancer	0.00036	0.00145	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000359	0.00145	CcSEcCtD
Sulfamethoxazole—Fatigue—Irinotecan—pancreatic cancer	0.000359	0.00145	CcSEcCtD
Sulfamethoxazole—Pruritus—Sunitinib—pancreatic cancer	0.000357	0.00144	CcSEcCtD
Sulfamethoxazole—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.000355	0.00143	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Fluorouracil—pancreatic cancer	0.000355	0.00143	CcSEcCtD
Sulfamethoxazole—Mental disorder—Docetaxel—pancreatic cancer	0.000355	0.00143	CcSEcCtD
Sulfamethoxazole—Malnutrition—Docetaxel—pancreatic cancer	0.000352	0.00142	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Gemcitabine—pancreatic cancer	0.000352	0.00142	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Fluorouracil—pancreatic cancer	0.000351	0.00141	CcSEcCtD
Sulfamethoxazole—Nausea—Tamoxifen—pancreatic cancer	0.00035	0.00141	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00035	0.00141	CcSEcCtD
Sulfamethoxazole—Fatigue—Gemcitabine—pancreatic cancer	0.000349	0.00141	CcSEcCtD
Sulfamethoxazole—Nausea—Erlotinib—pancreatic cancer	0.000347	0.0014	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Fluorouracil—pancreatic cancer	0.000346	0.0014	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Sunitinib—pancreatic cancer	0.000346	0.00139	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000344	0.00139	CcSEcCtD
Sulfamethoxazole—Ataxia—Doxorubicin—pancreatic cancer	0.000343	0.00138	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00034	0.00137	CcSEcCtD
Sulfamethoxazole—Eosinophilia—Epirubicin—pancreatic cancer	0.000338	0.00136	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Epirubicin—pancreatic cancer	0.000334	0.00135	CcSEcCtD
Sulfamethoxazole—Dizziness—Sunitinib—pancreatic cancer	0.000334	0.00135	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Irinotecan—pancreatic cancer	0.000329	0.00133	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Irinotecan—pancreatic cancer	0.000329	0.00133	CcSEcCtD
Sulfamethoxazole—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000329	0.00133	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Epirubicin—pancreatic cancer	0.000324	0.00131	CcSEcCtD
Sulfamethoxazole—Vomiting—Sunitinib—pancreatic cancer	0.000321	0.00129	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Gemcitabine—pancreatic cancer	0.00032	0.00129	CcSEcCtD
Sulfamethoxazole—Neutropenia—Epirubicin—pancreatic cancer	0.000319	0.00129	CcSEcCtD
Sulfamethoxazole—Rash—Sunitinib—pancreatic cancer	0.000318	0.00128	CcSEcCtD
Sulfamethoxazole—Dermatitis—Sunitinib—pancreatic cancer	0.000318	0.00128	CcSEcCtD
Sulfamethoxazole—Urticaria—Fluorouracil—pancreatic cancer	0.000317	0.00128	CcSEcCtD
Sulfamethoxazole—Headache—Sunitinib—pancreatic cancer	0.000316	0.00128	CcSEcCtD
Sulfamethoxazole—Leukopenia—Docetaxel—pancreatic cancer	0.000315	0.00127	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Fluorouracil—pancreatic cancer	0.000315	0.00127	CcSEcCtD
Sulfamethoxazole—Eosinophilia—Doxorubicin—pancreatic cancer	0.000312	0.00126	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000311	0.00125	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Doxorubicin—pancreatic cancer	0.000309	0.00125	CcSEcCtD
Sulfamethoxazole—Cough—Docetaxel—pancreatic cancer	0.000307	0.00124	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Irinotecan—pancreatic cancer	0.000307	0.00124	CcSEcCtD
Sulfamethoxazole—Pneumonia—Epirubicin—pancreatic cancer	0.000306	0.00123	CcSEcCtD
Sulfamethoxazole—Convulsion—Docetaxel—pancreatic cancer	0.000305	0.00123	CcSEcCtD
Sulfamethoxazole—Infestation—Epirubicin—pancreatic cancer	0.000304	0.00123	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Epirubicin—pancreatic cancer	0.000304	0.00123	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000302	0.00122	CcSEcCtD
Sulfamethoxazole—Myalgia—Docetaxel—pancreatic cancer	0.0003	0.00121	CcSEcCtD
Sulfamethoxazole—Arthralgia—Docetaxel—pancreatic cancer	0.0003	0.00121	CcSEcCtD
Sulfamethoxazole—Nausea—Sunitinib—pancreatic cancer	0.0003	0.00121	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Doxorubicin—pancreatic cancer	0.0003	0.00121	CcSEcCtD
Sulfamethoxazole—Renal failure—Epirubicin—pancreatic cancer	0.000299	0.0012	CcSEcCtD
Sulfamethoxazole—Asthenia—Irinotecan—pancreatic cancer	0.000298	0.0012	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000298	0.0012	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000298	0.0012	CcSEcCtD
Sulfamethoxazole—Stomatitis—Epirubicin—pancreatic cancer	0.000296	0.00119	CcSEcCtD
Sulfamethoxazole—Neutropenia—Doxorubicin—pancreatic cancer	0.000295	0.00119	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000294	0.00118	CcSEcCtD
Sulfamethoxazole—Asthenia—Gemcitabine—pancreatic cancer	0.000291	0.00117	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000288	0.00116	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000288	0.00116	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000288	0.00116	CcSEcCtD
Sulfamethoxazole—Pruritus—Gemcitabine—pancreatic cancer	0.000287	0.00116	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Irinotecan—pancreatic cancer	0.000285	0.00115	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Epirubicin—pancreatic cancer	0.000284	0.00114	CcSEcCtD
Sulfamethoxazole—Pneumonia—Doxorubicin—pancreatic cancer	0.000283	0.00114	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Docetaxel—pancreatic cancer	0.000282	0.00114	CcSEcCtD
Sulfamethoxazole—Pruritus—Fluorouracil—pancreatic cancer	0.000282	0.00114	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000282	0.00113	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Doxorubicin—pancreatic cancer	0.000281	0.00113	CcSEcCtD
Sulfamethoxazole—Infestation—Doxorubicin—pancreatic cancer	0.000281	0.00113	CcSEcCtD
Sulfamethoxazole—Skin disorder—Docetaxel—pancreatic cancer	0.000279	0.00113	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000279	0.00112	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Gemcitabine—pancreatic cancer	0.000277	0.00112	CcSEcCtD
Sulfamethoxazole—Renal failure—Doxorubicin—pancreatic cancer	0.000277	0.00111	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000276	0.00111	CcSEcCtD
Sulfamethoxazole—Dizziness—Irinotecan—pancreatic cancer	0.000275	0.00111	CcSEcCtD
Sulfamethoxazole—Stomatitis—Doxorubicin—pancreatic cancer	0.000274	0.00111	CcSEcCtD
Sulfamethoxazole—Anorexia—Docetaxel—pancreatic cancer	0.000274	0.0011	CcSEcCtD
Sulfamethoxazole—Hepatitis—Epirubicin—pancreatic cancer	0.000273	0.0011	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Fluorouracil—pancreatic cancer	0.000273	0.0011	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Epirubicin—pancreatic cancer	0.00027	0.00109	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000268	0.00108	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Epirubicin—pancreatic cancer	0.000268	0.00108	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000266	0.00107	CcSEcCtD
Sulfamethoxazole—Vomiting—Irinotecan—pancreatic cancer	0.000265	0.00107	CcSEcCtD
Sulfamethoxazole—Dizziness—Fluorouracil—pancreatic cancer	0.000263	0.00106	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000263	0.00106	CcSEcCtD
Sulfamethoxazole—Rash—Irinotecan—pancreatic cancer	0.000262	0.00106	CcSEcCtD
Sulfamethoxazole—Dermatitis—Irinotecan—pancreatic cancer	0.000262	0.00106	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000262	0.00106	CcSEcCtD
Sulfamethoxazole—Headache—Irinotecan—pancreatic cancer	0.000261	0.00105	CcSEcCtD
Sulfamethoxazole—Insomnia—Docetaxel—pancreatic cancer	0.00026	0.00105	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Epirubicin—pancreatic cancer	0.000258	0.00104	CcSEcCtD
Sulfamethoxazole—Vomiting—Gemcitabine—pancreatic cancer	0.000258	0.00104	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Docetaxel—pancreatic cancer	0.000256	0.00103	CcSEcCtD
Sulfamethoxazole—Rash—Gemcitabine—pancreatic cancer	0.000256	0.00103	CcSEcCtD
Sulfamethoxazole—Dermatitis—Gemcitabine—pancreatic cancer	0.000255	0.00103	CcSEcCtD
Sulfamethoxazole—Eye disorder—Epirubicin—pancreatic cancer	0.000255	0.00103	CcSEcCtD
Sulfamethoxazole—Tinnitus—Epirubicin—pancreatic cancer	0.000255	0.00103	CcSEcCtD
Sulfamethoxazole—Headache—Gemcitabine—pancreatic cancer	0.000254	0.00102	CcSEcCtD
Sulfamethoxazole—Vomiting—Fluorouracil—pancreatic cancer	0.000253	0.00102	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Docetaxel—pancreatic cancer	0.000253	0.00102	CcSEcCtD
Sulfamethoxazole—Hepatitis—Doxorubicin—pancreatic cancer	0.000253	0.00102	CcSEcCtD
Sulfamethoxazole—Rash—Fluorouracil—pancreatic cancer	0.000251	0.00101	CcSEcCtD
Sulfamethoxazole—Dermatitis—Fluorouracil—pancreatic cancer	0.000251	0.00101	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Docetaxel—pancreatic cancer	0.00025	0.00101	CcSEcCtD
Sulfamethoxazole—Headache—Fluorouracil—pancreatic cancer	0.00025	0.00101	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000249	0.00101	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000248	0.001	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000248	0.001	CcSEcCtD
Sulfamethoxazole—Fatigue—Docetaxel—pancreatic cancer	0.000248	0.000999	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Doxorubicin—pancreatic cancer	0.000248	0.000998	CcSEcCtD
Sulfamethoxazole—Nausea—Irinotecan—pancreatic cancer	0.000247	0.000996	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Epirubicin—pancreatic cancer	0.000247	0.000994	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000246	0.000992	CcSEcCtD
Sulfamethoxazole—Chills—Epirubicin—pancreatic cancer	0.000245	0.000987	CcSEcCtD
Sulfamethoxazole—Nausea—Gemcitabine—pancreatic cancer	0.000241	0.00097	CcSEcCtD
Sulfamethoxazole—Mental disorder—Epirubicin—pancreatic cancer	0.000239	0.000964	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000239	0.000963	CcSEcCtD
Sulfamethoxazole—Malnutrition—Epirubicin—pancreatic cancer	0.000238	0.000958	CcSEcCtD
Sulfamethoxazole—Nausea—Fluorouracil—pancreatic cancer	0.000237	0.000954	CcSEcCtD
Sulfamethoxazole—Eye disorder—Doxorubicin—pancreatic cancer	0.000236	0.000951	CcSEcCtD
Sulfamethoxazole—Tinnitus—Doxorubicin—pancreatic cancer	0.000236	0.000949	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000235	0.000948	CcSEcCtD
Sulfamethoxazole—Tension—Epirubicin—pancreatic cancer	0.000233	0.00094	CcSEcCtD
Sulfamethoxazole—Nervousness—Epirubicin—pancreatic cancer	0.000231	0.00093	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Doxorubicin—pancreatic cancer	0.000228	0.00092	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000228	0.000918	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Docetaxel—pancreatic cancer	0.000227	0.000916	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Docetaxel—pancreatic cancer	0.000227	0.000916	CcSEcCtD
Sulfamethoxazole—Chills—Doxorubicin—pancreatic cancer	0.000227	0.000914	CcSEcCtD
Sulfamethoxazole—Mental disorder—Doxorubicin—pancreatic cancer	0.000221	0.000892	CcSEcCtD
Sulfamethoxazole—Malnutrition—Doxorubicin—pancreatic cancer	0.00022	0.000886	CcSEcCtD
Sulfamethoxazole—Tension—Doxorubicin—pancreatic cancer	0.000216	0.00087	CcSEcCtD
Sulfamethoxazole—Nervousness—Doxorubicin—pancreatic cancer	0.000214	0.000861	CcSEcCtD
Sulfamethoxazole—Vertigo—Epirubicin—pancreatic cancer	0.000214	0.000861	CcSEcCtD
Sulfamethoxazole—Leukopenia—Epirubicin—pancreatic cancer	0.000213	0.000857	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Docetaxel—pancreatic cancer	0.000212	0.000854	CcSEcCtD
Sulfamethoxazole—Cough—Epirubicin—pancreatic cancer	0.000207	0.000836	CcSEcCtD
Sulfamethoxazole—Asthenia—Docetaxel—pancreatic cancer	0.000206	0.000832	CcSEcCtD
Sulfamethoxazole—Convulsion—Epirubicin—pancreatic cancer	0.000206	0.00083	CcSEcCtD
Sulfamethoxazole—Pruritus—Docetaxel—pancreatic cancer	0.000203	0.00082	CcSEcCtD
Sulfamethoxazole—Myalgia—Epirubicin—pancreatic cancer	0.000202	0.000815	CcSEcCtD
Sulfamethoxazole—Arthralgia—Epirubicin—pancreatic cancer	0.000202	0.000815	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000201	0.00081	CcSEcCtD
Sulfamethoxazole—Vertigo—Doxorubicin—pancreatic cancer	0.000198	0.000796	CcSEcCtD
Sulfamethoxazole—Leukopenia—Doxorubicin—pancreatic cancer	0.000197	0.000793	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Docetaxel—pancreatic cancer	0.000197	0.000793	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000194	0.000782	CcSEcCtD
Sulfamethoxazole—Cough—Doxorubicin—pancreatic cancer	0.000192	0.000773	CcSEcCtD
Sulfamethoxazole—Convulsion—Doxorubicin—pancreatic cancer	0.000191	0.000768	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Epirubicin—pancreatic cancer	0.00019	0.000767	CcSEcCtD
Sulfamethoxazole—Dizziness—Docetaxel—pancreatic cancer	0.00019	0.000766	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Epirubicin—pancreatic cancer	0.00019	0.000765	CcSEcCtD
Sulfamethoxazole—Skin disorder—Epirubicin—pancreatic cancer	0.000188	0.000759	CcSEcCtD
Sulfamethoxazole—Myalgia—Doxorubicin—pancreatic cancer	0.000187	0.000755	CcSEcCtD
Sulfamethoxazole—Arthralgia—Doxorubicin—pancreatic cancer	0.000187	0.000755	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000186	0.000749	CcSEcCtD
Sulfamethoxazole—Anorexia—Epirubicin—pancreatic cancer	0.000185	0.000745	CcSEcCtD
Sulfamethoxazole—Vomiting—Docetaxel—pancreatic cancer	0.000183	0.000737	CcSEcCtD
Sulfamethoxazole—Rash—Docetaxel—pancreatic cancer	0.000181	0.000731	CcSEcCtD
Sulfamethoxazole—Dermatitis—Docetaxel—pancreatic cancer	0.000181	0.00073	CcSEcCtD
Sulfamethoxazole—Headache—Docetaxel—pancreatic cancer	0.00018	0.000726	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000179	0.000723	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000177	0.000712	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000176	0.000709	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000176	0.000708	CcSEcCtD
Sulfamethoxazole—Insomnia—Epirubicin—pancreatic cancer	0.000175	0.000707	CcSEcCtD
Sulfamethoxazole—Skin disorder—Doxorubicin—pancreatic cancer	0.000174	0.000703	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Epirubicin—pancreatic cancer	0.000173	0.000697	CcSEcCtD
Sulfamethoxazole—Anorexia—Doxorubicin—pancreatic cancer	0.000171	0.00069	CcSEcCtD
Sulfamethoxazole—Nausea—Docetaxel—pancreatic cancer	0.000171	0.000688	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Epirubicin—pancreatic cancer	0.000171	0.000688	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Epirubicin—pancreatic cancer	0.000169	0.00068	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000167	0.000675	CcSEcCtD
Sulfamethoxazole—Fatigue—Epirubicin—pancreatic cancer	0.000167	0.000674	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000164	0.000659	CcSEcCtD
Sulfamethoxazole—Insomnia—Doxorubicin—pancreatic cancer	0.000162	0.000654	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Doxorubicin—pancreatic cancer	0.00016	0.000645	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000159	0.000639	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Doxorubicin—pancreatic cancer	0.000158	0.000637	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Doxorubicin—pancreatic cancer	0.000156	0.000629	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000155	0.000624	CcSEcCtD
Sulfamethoxazole—Fatigue—Doxorubicin—pancreatic cancer	0.000155	0.000624	CcSEcCtD
Sulfamethoxazole—Urticaria—Epirubicin—pancreatic cancer	0.000154	0.000621	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Epirubicin—pancreatic cancer	0.000153	0.000618	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Epirubicin—pancreatic cancer	0.000153	0.000618	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000147	0.000591	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Epirubicin—pancreatic cancer	0.000143	0.000576	CcSEcCtD
Sulfamethoxazole—Urticaria—Doxorubicin—pancreatic cancer	0.000143	0.000575	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Doxorubicin—pancreatic cancer	0.000142	0.000572	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Doxorubicin—pancreatic cancer	0.000142	0.000572	CcSEcCtD
Sulfamethoxazole—Asthenia—Epirubicin—pancreatic cancer	0.000139	0.000561	CcSEcCtD
Sulfamethoxazole—Pruritus—Epirubicin—pancreatic cancer	0.000137	0.000553	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Epirubicin—pancreatic cancer	0.000133	0.000535	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000132	0.000533	CcSEcCtD
Sulfamethoxazole—Asthenia—Doxorubicin—pancreatic cancer	0.000129	0.000519	CcSEcCtD
Sulfamethoxazole—Dizziness—Epirubicin—pancreatic cancer	0.000128	0.000517	CcSEcCtD
Sulfamethoxazole—Pruritus—Doxorubicin—pancreatic cancer	0.000127	0.000512	CcSEcCtD
Sulfamethoxazole—Vomiting—Epirubicin—pancreatic cancer	0.000123	0.000497	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Doxorubicin—pancreatic cancer	0.000123	0.000495	CcSEcCtD
Sulfamethoxazole—Rash—Epirubicin—pancreatic cancer	0.000122	0.000493	CcSEcCtD
Sulfamethoxazole—Dermatitis—Epirubicin—pancreatic cancer	0.000122	0.000492	CcSEcCtD
Sulfamethoxazole—Headache—Epirubicin—pancreatic cancer	0.000122	0.00049	CcSEcCtD
Sulfamethoxazole—Dizziness—Doxorubicin—pancreatic cancer	0.000119	0.000478	CcSEcCtD
Sulfamethoxazole—Nausea—Epirubicin—pancreatic cancer	0.000115	0.000464	CcSEcCtD
Sulfamethoxazole—Vomiting—Doxorubicin—pancreatic cancer	0.000114	0.00046	CcSEcCtD
Sulfamethoxazole—Rash—Doxorubicin—pancreatic cancer	0.000113	0.000456	CcSEcCtD
Sulfamethoxazole—Dermatitis—Doxorubicin—pancreatic cancer	0.000113	0.000456	CcSEcCtD
Sulfamethoxazole—Headache—Doxorubicin—pancreatic cancer	0.000112	0.000453	CcSEcCtD
Sulfamethoxazole—Nausea—Doxorubicin—pancreatic cancer	0.000107	0.00043	CcSEcCtD
